2171.HK
Price:
$11.82
Market Cap:
$5.74B
CARsgen Therapeutics Holdings Limited, a biopharmaceutical firm founded in Shanghai, China, in 2014, focuses on the discovery, development, and commercialization of advanced chimeric antigen receptor T (CAR-T) cell therapies. The company's efforts are directed toward treating various hematological malignancies and solid tumors across China and the United States. Its robust pipeline includes several key candidates: CT053, an autologous CAR-T product, is currently in a pivotal Phase II trial in China for relapsed/refractory multiple myeloma. Additionally, CT041, another autologous CAR-T, is undergoing Phase Ib/II clinical trials for advanced gastric/gastroesophageal junction and pancreatic can...[Read more]
Industry
Biotechnology
IPO Date
2021-06-18
Stock Exchange
HKSE
Ticker
2171.HK
According to CARsgen Therapeutics Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 4.41B. This represents a change of -31.50% compared to the average of 6.44B of the last 4 quarters.
The mean historical Enterprise Value of CARsgen Therapeutics Holdings Limited over the last ten years is 4.84B. The current 4.41B Enterprise Value has changed 9.02% with respect to the historical average. Over the past ten years (40 quarters), 2171.HK's Enterprise Value was at its highest in in the December 2021 quarter at 11.97B. The Enterprise Value was at its lowest in in the June 2024 quarter at 1.03B.
Average
4.84B
Median
4.06B
Minimum
1.40B
Maximum
11.96B
Discovering the peaks and valleys of CARsgen Therapeutics Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 194.77%
Maximum Annual Enterprise Value = 11.96B
Minimum Annual Increase = -72.80%
Minimum Annual Enterprise Value = 1.40B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 6.30B | 81.59% |
| 2024 | 3.47B | 147.84% |
| 2023 | 1.40B | -72.80% |
| 2022 | 5.15B | -56.96% |
| 2021 | 11.96B | 194.77% |
| 2020 | 4.06B | 169.06% |
The current Enterprise Value of CARsgen Therapeutics Holdings Limited (2171.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.72B
5-year avg
5.66B
10-year avg
4.84B
CARsgen Therapeutics Holdings Limited’s Enterprise Value is greater than JW (Cayman) Therapeutics Co. Ltd (823.25M), greater than Immunotech Biopharm Ltd (538.74M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 823.25M | $1.13B | |
| 538.74M | $237.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CARsgen Therapeutics Holdings Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CARsgen Therapeutics Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CARsgen Therapeutics Holdings Limited's Enterprise Value?
What is the highest Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK)?
What is the 3-year average Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK)?
What is the 5-year average Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK)?
How does the current Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK) compare to its historical average?